Methods and compositions for increasing sensitivity to tyrosine kinase inhibitors

Details for Australian Patent Application No. 2010324530 (hide)

Owner The University of Western Australia

Inventors Leedman, Peter Jeffery; Giles, Keith Michael; Kalinowski, Felicity Caris

Agent Davies Collison Cave

Pub. Number AU-A-2010324530

PCT Pub. Number WO2011/063456

Priority 2009905758 24.11.09 AU

Filing date 24 November 2010

Wipo publication date 3 June 2011

International Classifications

A61K 31/7105 - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 31/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 Antineoplastic agents

Event Publications

19 July 2012 PCT application entered the National Phase

  PCT publication WO2011/063456 Priority application(s): WO2011/063456

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010324532-Membrane and membrane separation system

2010324529-Modulation of epidermal growth factor receptor ligands